Citi Starts SAB Biotherapeutics (SABS) at Buy May 22, 2026 05:08AM
SAB Biotherapeutics prices $85 million public offering at $3.85 per share Mar 17, 2026 10:46PM
SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants Mar 17, 2026 10:46PM